This inventor holds 2 USPTO granted patents. Top assignee: Sanofi-Aventis. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Innovator Spotlight: Joerg Reike-Zapp
Introduction:
Joerg Reike-Zapp, based in Frankfurt-am-Main, Germany, is a notable inventor recognized for his contributions in the field of pharmaceutical chemistry. With a total of two patents to his name, he has developed innovative methods that enhance the synthesis process of specific chemical compounds.
Latest Patents:
Joerg's latest patents include a significant breakthrough in the preparation of derivatives related to N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamide. His work involves a novel method for synthesizing N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide, offering new avenues for pharmaceutical development.
Career Highlights:
He is currently associated with Sanofi-Aventis, a global leader in the pharmaceutical industry. In his role, Joerg has played a critical part in developing innovative solutions that address complex healthcare challenges.
Collaborations:
Joerg collaborates with esteemed colleagues, including Philippe Boffelli and Michel Delthil. These partnerships have fostered a collaborative environment, driving innovation and contributing to the advancements in their field.
Conclusion:
Joerg Reike-Zapp's innovative work and patents reflect his commitment to enhancing pharmaceutical processes. His contributions not only advance scientific knowledge but also pave the way for potential healthcare solutions that can benefit society at large.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile